Patents by Inventor Miyoung OH

Miyoung OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Refrigerator for entrance gate
    Patent number: 11980310
    Abstract: A controller for a refrigerator for an entrance gate according to an embodiment of the present invention is configured to: register a user authentication means through a user authentication method setting process; and to open an outer door only when user authentication has succeeded, if an article delivery command is input, thereby preventing theft of the article.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: May 14, 2024
    Assignee: LG ELECTRONICS INC.
    Inventors: Seojin Lee, Wonjin Lee, Insun Yeo, Eugene Myung, Miyoung Seo, Kyukwan Choi, Minkyu Oh, Yezo Yun
  • Refrigerator
    Patent number: 11918131
    Abstract: The present invention relates to a front door refrigerator for enabling a delivery man to safely deliver delivery goods to an orderer even when a user having ordered an item or fresh food is not at home, and preventing the delivery goods from becoming lost during delivery.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: March 5, 2024
    Assignee: LG ELECTRONICS INC.
    Inventors: Seojin Lee, Wonjin Lee, Insun Yeo, Eugene Myung, Miyoung Seo, Kyukwan Choi, Yezo Yun, Minkyu Oh
  • Anti-CEACAM1 antibody and use thereof
    Patent number: 11332528
    Abstract: The present invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1, and a use thereof. Anti-CEACAM1 antibodies according to the present invention exhibit superior binding abilities specific to CEACAM1, and also activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells, and thus, each one of them can be effectively used as an anti-cancer agent and a composition for treating cancer.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: May 17, 2022
    Assignees: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: So-Young Eun, Miyoung Oh, Hye-Young Park, Mijung Lee, Aerin Yoon, Hye In Yum, Hyemi Nam, Eunhee Lee, Jongwha Won
  • Anti-mesothelin antibody and composition comprising the same
    Patent number: 10851175
    Abstract: The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: December 1, 2020
    Assignees: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: Dong-Sik Kim, Eun Jung Song, Mijung Lee, Eun-Hee Lee, Miyoung Oh, Jae Chan Park, Kisu Kim, Sujeong Kim, Hyung-Kwon Lim, Kyuhyun Lee, Jongwha Won, Soongyu Choi, Young Seoub Park
  • ANTI-CEACAM1 ANTIBODY AND USE THEREOF
    Publication number: 20200109196
    Abstract: The present invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1, and a use thereof. Anti-CEACAM1 antibodies according to the present invention exhibit superior binding abilities specific to CEACAM1, and also activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells, and thus, each one of them can be effectively used as an anti-cancer agent and a composition for treating cancer.
    Type: Application
    Filed: March 23, 2018
    Publication date: April 9, 2020
    Applicants: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: So-Young EUN, Miyoung OH, Hye-Young PARK, Mijung LEE, Aerin YOON, Hye In YUM, Hyemi NAM, Eunhee LEE, Jongwha WON
  • NOVEL ANTI-MESOTHELIN ANTIBODY AND COMPOSITION COMPRISING THE SAME
    Publication number: 20180346588
    Abstract: The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.
    Type: Application
    Filed: September 23, 2016
    Publication date: December 6, 2018
    Applicants: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATION
    Inventors: Dong-Sik KIM, Eun Jung SONG, Mijung LEE, Eun-Hee LEE, Miyoung OH, Jae Chan PARK, Kisu KIM, Sujeong KIM, Hyung-Kwon LIM, Kyuhyun LEE, Jongwha WON, Soongyu CHOI, Young Seoub PARK